Global Cytomegalovirus (CMV) Therapeutics Market 2024-2028
상품코드:1581113
리서치사:TechNavio
발행일:2024년 10월
페이지 정보:영문 144 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
거대세포바이러스(CMV) 치료제 시장(2024-2028년)
거대세포바이러스(CMV) 치료제 시장은 2023-2028년에 2억 7,040만 달러로 확대하며, 예측 기간 중 4.5%의 CAGR로 성장할 것으로 예측됩니다. 거대세포바이러스(CMV) 치료제 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25사의 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 이 시장은 CMV의 리스크 요인 증가, 질환의 재발성, 선천성 CMV의 높은 유병률에 의해 촉진되고 있습니다.
시장 범위
기준년
2024년
종료년
2028년
예측 기간
2024-2028년
성장 모멘텀
가속
전년대비(2024년)
4.2%
CAGR
4.5%
증분액
2억 7,040만 달러
향후 수년간 거대세포바이러스(CMV) 치료제 시장 성장을 촉진하는 주요 요인의 하나로 약제의 개질을 들고 있습니다. 또한 백신 및 신생아 스크리닝의 등장은 시장의 큰 수요로 연결됩니다.
The cytomegalovirus (CMV) therapeutics market is forecasted to grow by USD 270.4 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the cytomegalovirus (CMV) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing risk factors for cmv, recurring nature of the disease, and high prevalence of congenital cmv.
Market Scope
Base Year
2024
End Year
2028
Series Year
2024-2028
Growth Momentum
Accelerate
YOY 2024
4.2%
CAGR
4.5%
Incremental Value
$270.4 mn
Technavio's cytomegalovirus (CMV) therapeutics market is segmented as below:
By Route Of Administration
Oral
Parenteral
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the reformulation of drugs as one of the prime reasons driving the cytomegalovirus (CMV) therapeutics market growth during the next few years. Also, advent of vaccines and newborn screening will lead to sizable demand in the market.
The report on the cytomegalovirus (CMV) therapeutics market covers the following areas:
Cytomegalovirus (CMV) Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cytomegalovirus (CMV) therapeutics market vendors that include Astellas Pharma Inc., AstraZeneca Plc, Bausch Lomb Corp., Chimerix Inc., Clinigen Group Plc, Exela Pharma Sciences LLC, F. Hoffmann La Roche Ltd., Fortress Biotech Inc., Fresenius SE and Co. KGaA, Genentech Inc., Gilead Sciences Inc., Merck and Co. Inc., ProBioGen AG, Synklino AS, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., UbiVac, and VBI Vaccines Inc.. Also, the cytomegalovirus (CMV) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Cytomegalovirus (CMV) Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Cytomegalovirus (CMV) Therapeutics Market 2018 - 2022 ($ million)
4.2 Route of Administration segment analysis 2018 - 2022
